In Q2 fiscal 2026 (the quarter ended June 30, 2026), Elanco Animal Health's largest product or service was Pet Health, with $718.00 million or 52% of revenue, up 11.7% from a year earlier. Next: Farm Animal (46%) and Contract Manufacturing (1%).
By region, Non-US brought in 52% and United States brought in 48% of revenue in Q2 fiscal 2026.
By country, Non-US brought in 52% and UNITED STATES brought in 48% of revenue in Q2 fiscal 2026.
The fastest-growing product or service from a year earlier was Pet Health (+11.7%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Pet Health | $718.0M | $710.0M | $533.0M | $643.0M | 52% |
| Farm Animal | $633.0M | $642.0M | $593.0M | $583.0M | 46% |
| Contract Manufacturing | $17.0M | $19.0M | $11.0M | $15.0M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Non-US | $705.0M | $766.0M | $590.0M | $648.0M | 52% |
| United States | $663.0M | $605.0M | $547.0M | $593.0M | 48% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Country | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Non-US | $705.0M | $766.0M | $590.0M | $648.0M | 52% |
| UNITED STATES | $663.0M | $605.0M | $547.0M | $593.0M | 48% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Pet Health: $718.00 million, or 52% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Pet Health (52%), Farm Animal (46%) and Contract Manufacturing (1%).
By region in Q2 fiscal 2026: Non-US (52%) and United States (48%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item |
|---|